- Global Pharma News & Resources

Cost-effective and Convenience – Two Major Aspects Expected to Boost the Sales of Oscillating Positive Expiratory Pressure Devices

Future Market Insights recently published a market research report that offers resourceful insights related to the growth trajectory of the oscillating positive expiratory pressure devices market during the forecast period, 2019-2029. The report provides an in-depth analysis of the various factors that are likely to influence the overall dynamics of the global oscillating positive expiratory pressure (OPEP) market including the trends, growth opportunities, restraints, and challenges. According to the report, the estimated market value of the global oscillating positive expiratory pressure devices market was ~US$ 100 million in 2018 and the market is expected to grow at a compounded annual growth rate (CAGR) of ~5% during the forecast period.

The market growth can be attributed to a range of factors including, significant growth in the regional availability of oscillating positive expiratory pressure devices, growing inclination towards innovation among manufacturers to develop new products and high demand for oscillating positive expiratory pressure devices (OPEP) among patients suffering from respiratory conditions. In addition, the convenience offered by OPEP devices in terms of usage is another factor that is expected to boost the sales of the oscillating positive expiratory devices in the upcoming years.

Growing prevalence of respiratory diseases expected to boost demand for OPEP devices

Respiratory diseases are often caused due to the production of mucus and require effective medical therapies to clear the airway. In addition, as oscillating positive expiratory pressure devices offer the desired results, it has emerged as one of the most effective alternative therapies to deal with respiratory devices. In the current scenario, a notable growth in the number of respiratory diseases among patients worldwide can be observed which in turn is boosting the demand for oscillating positive expiratory devices in recent times and the trend is likely to continue in the upcoming years.

OPEP devices emerge as a cost-effective solution to manage pulmonary diseases

Treatment of pulmonary diseases is often associated with high costs owing to the prolonged nature of the condition. However, the onset of innovative and highly effective oscillating positive expiratory pressure devices assist in eliminating mucus. Moreover, the production of mucus interferes with the management of cystic fibrosis and often adds to the costs required to treat respiratory diseases. However, oscillating positive expiratory pressure devices significantly assist in removing mucus regularly – a major factor that is boosting the efficacy of drug administration during the treatment of pulmonary diseases. Hence, oscillating positive expiratory pressure devices have emerged as a cost-effective solution to treat pulmonary diseases.

To know more about this market, request a sample@

Oscillating Positive Expiratory Devices Market: Vendor Insights The report offers resourceful data related to the major companies operating in the current oscillating positive expiratory devices market such as the growth strategies, product portfolio, pricing analysis, and more. Some of the prominent market players operating in the market are, Smiths Medical, Inc., Allergan plc., R.Cegla GmbH & Co.KG, Monaghan Medical Corporation & Trudell Medical International, PARI GmbH, WyMedical Pty Ltd, AirPhysio, and Medica Holdings, LLC., among others.

Editor Details

Last Updated: 03-Mar-2021